Applied Therapeutics Recommends Tendering Shares Following Offer Expiration Extension

Applied Therapeutics released a letter to stockholders recommending the tender of shares following the extension of an offer expiration date. The company entered a merger agreement with Cycle Group Holdings for Cycle to acquire Applied Therapeutics. The merger represents the best path forward to bring govorestat, a potentially life-changing therapy for rare diseases, closer to patients. If less than the requisite percentage of shares are tendered, the offer cannot be completed, and the company may pursue a wind-down of its operations or liquidation.